John Maraganore - Jan 17, 2022 Form 3 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Jan 17, 2022
Transactions value $
$0
Form type
3
Date filed
1/19/2022, 04:30 PM
Previous filing
Dec 23, 2021
Next filing
Jan 19, 2022

No securities are beneficially owned.